Related Experiment Video
Updated: Aug 13, 2026
A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent
Published on: November 2, 2013
STI571 inhibits growth and adhesion of human mast cells in culture
Kouichi Takeuchi1, Kenichi Koike, Takehiko Kamijo
1Department of Pediatrics, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, 390-8621, Japan.
Abstract:
Stem cell factor (SCF)/c-kit system is critical for human mast cell development. We thus examined the effects of STI571, an inhibitor of the c-kit tyrosine kinase receptor, on the proliferation and function of human mast cells. STI571 at concentrations of 10(-6) M or higher almost completely abolished the SCF-dependent progeny generation from cord blood-derived cultured mast cells through an inhibition of the tyrosine phosphorylation of c-kit. The compound also suppressed the early phase of mast cell development. The extinction of mast cell growth induced by STI571 may be due largely to apoptosis according to the flow cytometric analysis and gel electrophoresis. Two-hour exposure to STI571 that failed to influence the total viable cell number suppressed adhesion of the cells to fibronectin in the presence of SCF without altering the expressions of integrin molecules. Our results may provide a fundamental insight for the clinical application of STI571 in allergic disorders.
Insights
The tyrosine kinase inhibitor STI571 blocks stem cell factor (SCF)-driven human mast cell development by inhibiting c-kit phosphorylation. This leads to apoptosis and suppressed mast cell function, offering insights for treating allergic disorders.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- The stem cell factor (SCF)/c-kit signaling pathway is essential for human mast cell development and function.
- Mast cells play a crucial role in allergic responses.
- Understanding the regulation of mast cell development is key to developing new therapies for allergic diseases.
Purpose of the Study:
- To investigate the effects of STI571, a c-kit tyrosine kinase receptor inhibitor, on human mast cell proliferation and function.
- To elucidate the mechanisms by which STI571 impacts mast cell development.
- To assess the potential of STI571 as a therapeutic agent for allergic disorders.
Main Methods:
- Utilized cord blood-derived cultured mast cells.
- Administered STI571 at concentrations of 10(-6) M and higher.
- Assessed SCF-dependent progeny generation and c-kit tyrosine phosphorylation.
- Analyzed mast cell development, apoptosis (flow cytometry, gel electrophoresis), and adhesion to fibronectin.
- Evaluated integrin molecule expression.
Main Results:
- STI571 (≥10(-6) M) abolished SCF-dependent mast cell progeny generation by inhibiting c-kit tyrosine phosphorylation.
- The compound suppressed early mast cell development, likely through apoptosis induction.
- Short-term STI571 exposure reduced mast cell adhesion to fibronectin without affecting integrin expression.
Conclusions:
- STI571 effectively inhibits human mast cell development and function by targeting the c-kit pathway.
- The induction of apoptosis and suppression of adhesion are key mechanisms of STI571's action.
- These findings suggest STI571 holds promise for clinical applications in managing allergic disorders.
